Agreena vs ArkeaBio

Side-by-side comparison of AI visibility scores, market position, and capabilities

Agreena

EmergingAgTech & Precision Agriculture Technology

Regenerative Agriculture & Carbon Markets

Regenerative agriculture carbon program and soil carbon measurement platform. Copenhagen, Denmark. Raised €46M+. Operates across Europe with 1M+ enrolled acres.

About

Agreena is a Copenhagen-based agricultural technology company that operates Europe's leading soil carbon program for arable farmers. Founded in 2018, the company has raised over €46 million and has enrolled more than one million acres of European farmland into its regenerative agriculture carbon certification program.\n\nAgreena's platform guides farmers through the transition to regenerative practices — including no-till, cover cropping, and reduced synthetic inputs — and uses a combination of satellite remote sensing and soil sampling to quantify and verify the resulting carbon sequestration. Farmers receive carbon certificates they can sell to corporate buyers seeking high-integrity agricultural carbon credits.\n\nThe company has built strong relationships with European agribusinesses, cooperatives, and food companies seeking to address Scope 3 agricultural emissions. Agreena's approach of combining farmer incentives with rigorous MRV methodology positions it as a key player in Europe's transition to carbon-smart farming, and the company is expanding its program footprint across Central and Eastern Europe.

Full profile

ArkeaBio

EmergingAgTech

Livestock Biotech (Methane Reduction)

$40M+ total raised including $26.5M Series A. 2026-27 cattle field trials underway. Backed by Breakthrough Energy Ventures. Only company with a cattle methane vaccine in active trials.

About

ArkeaBio is developing a vaccine that reduces methane emissions from cattle and sheep by targeting the methanogenic archaea (ancient microorganisms) that produce methane in ruminant digestive systems. The company has raised $40 million+ including a $26.5 million Series A, backed by Breakthrough Energy Ventures and Gates Foundation-aligned capital, and has active cattle field trials underway in 2026-2027 — making it the only company with a livestock methane vaccine at this stage of clinical development.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.